Literature DB >> 20445192

Prophylactic eculizumab after renal transplantation in atypical hemolytic-uremic syndrome.

Lothar Bernd Zimmerhackl, Johannes Hofer, Gérard Cortina, Walter Mark, Reinhard Würzner, Therese C Jungraithmayr, Gus Khursigara, Kay O Kliche, Wolfgang Radauer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20445192     DOI： 10.1056/NEJMc1001060

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  58 in total

1.  Thrombotic microangiopathy: atypical HUS: current diagnostic and therapeutic approaches.

Authors:  Alejandra Rosales; Magdalena Riedl; Lothar B Zimmerhackl
Journal:  Nat Rev Nephrol       Date:  2010-09       Impact factor: 28.314

Review 2.  Therapeutic plasma exchange for the treatment of pediatric renal diseases in 2013.

Authors:  Caitlin E Carter; Nadine M Benador
Journal:  Pediatr Nephrol       Date:  2013-06-29       Impact factor: 3.714

Review 3.  Immunosuppressive drug therapy.

Authors:  Choli Hartono; Thangamani Muthukumar; Manikkam Suthanthiran
Journal:  Cold Spring Harb Perspect Med       Date:  2013-09-01       Impact factor: 6.915

Review 4.  Current state of renal transplant immunosuppression: Present and future.

Authors:  Hari Varun Kalluri; Karen L Hardinger
Journal:  World J Transplant       Date:  2012-08-24

5.  Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype.

Authors:  Elena Bresin; Erica Rurali; Jessica Caprioli; Pilar Sanchez-Corral; Veronique Fremeaux-Bacchi; Santiago Rodriguez de Cordoba; Sheila Pinto; Timothy H J Goodship; Marta Alberti; David Ribes; Elisabetta Valoti; Giuseppe Remuzzi; Marina Noris
Journal:  J Am Soc Nephrol       Date:  2013-02-21       Impact factor: 10.121

6.  Effect of eculizumab and recombinant human soluble thrombomodulin combination therapy in a 7-year-old girl with atypical hemolytic uremic syndrome due to anti-factor H autoantibodies.

Authors:  Tomohiro Udagawa; Yaeko Motoyoshi; Yu Matsumura; Akira Takei; Shohei Ariji; Eisaku Ito; Motoko Chiga; Masayuki Nagasawa; Tomohiro Morio; Shuki Mizutani
Journal:  CEN Case Rep       Date:  2013-09-12

Review 7.  Guidelines for the management and investigation of hemolytic uremic syndrome.

Authors:  Takashi Igarashi; Shuichi Ito; Mayumi Sako; Akihiko Saitoh; Hiroshi Hataya; Masashi Mizuguchi; Tsuneo Morishima; Kenji Ohnishi; Naohisa Kawamura; Hirotsugu Kitayama; Akira Ashida; Shinya Kaname; Hiromichi Taneichi; Julian Tang; Makoto Ohnishi
Journal:  Clin Exp Nephrol       Date:  2014-08       Impact factor: 2.801

8.  Pre-emptive eculizumab and plasmapheresis for renal transplant in atypical hemolytic uremic syndrome.

Authors:  Carla Nester; Zoe Stewart; David Myers; Jennifer Jetton; Ramesh Nair; Alan Reed; Christie Thomas; Richard Smith; Patrick Brophy
Journal:  Clin J Am Soc Nephrol       Date:  2011-05-26       Impact factor: 8.237

Review 9.  Hemolytic uremic syndrome.

Authors:  Caterina Mele; Giuseppe Remuzzi; Marina Noris
Journal:  Semin Immunopathol       Date:  2014-02-14       Impact factor: 9.623

Review 10.  Advances and challenges in the management of complement-mediated thrombotic microangiopathies.

Authors:  Jean-Claude Davin; Nicole C A J van de Kar
Journal:  Ther Adv Hematol       Date:  2015-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.